Collaborating with us

Delivery focused

Historically, sponsors have faced a polarised choice of CRO: global corporations that are inflexible and prohibitively expensive; or cheaper local suppliers who may lack sufficient resources or expertise. As your full-service, pan-European CRO partner we offer an ideal size, reliable, rigorously compliant and cost competitive alternative.

95%+

Repeat business

100%

of clients would collaborate on future studies

100%

of clients would recommend us to others

We can demonstrate a track record for consistently delivering accelerated project start-ups, over-achieving patient recruitment targets and completing studies ahead of schedule.

Our collaborative and commercially minded approach, combined with our market-leading access to cost-effective and participant-rich locations in Central, Southern and South-Eastern Europe, mean you can have confidence in our ability to meet your budget requirements.

Our people, your greatest asset

The success of a clinical trial is fundamentally dependent upon the expertise, experience and commitment of your CRO team.

Our reputation for operational excellence is founded on the quality of our highly educated staff: 29% have a higher degree; 70% hold an M.Sc. and B.Sc in pharmacy or life sciences; and 16% of the team are qualified Medical Doctors.
On average, our Clinical Operations team have more than seven years research experience while the members of our Clinical Project Management department bring an average of more than 11 years of practical know-how.
All of this, combined with an industry-leading staff turnover rate of less than 10%, means that your Optimapharm team is likely to remain consistently robust and efficient throughout the duration of your study.
Our established global network facilitates quick and easy access to key opinion leaders and world-class therapeutic area expertise when it is necessary to expedite a clinical trial.

“It has been great working with Optimapharm during 2018, you have exceeded the expectations. Thank you for all you have done and are doing for us. I look forward to even better collaboration during 2019.”

Country Head

Let’s talk about your pharma study needs